Silexion Therapeutics (SLXN) Total Liabilities (2023 - 2026)
Silexion Therapeutics (SLXN) posted quarterly Total Liabilities of $4.3 million for Q1 2026, down 24.66% year-over-year from $5.7 million in Q1 2025, and down 6.53% quarter-over-quarter from $4.6 million in Q4 2025.
Silexion Therapeutics (SLXN) Total Liabilities (2023 - 2026) Analysis & Trends
Silexion Therapeutics' Total Liabilities history runs 4 years deep, the most recent figure standing at $4.3 million for Q1 2026.
- In Q1 2026, Total Liabilities fell 24.66% year-over-year to $4.3 million; the TTM figure through Mar 2026 stood at $4.3 million (down 24.66% YoY), while the FY2025 annual figure was $4.6 million, down 32.69% from the prior year.
- Total Liabilities for Q1 2026 stood at $4.3 million, down from $4.6 million in the prior quarter.
- The five-year high for Total Liabilities was $7.7 million in Q3 2024, with the low at $2.3 million in Q4 2023.
- The 4-year median for Total Liabilities is $4.6 million (2025), against an average of $4.8 million.
- The sharpest annual moves came in 2024 and 2025: Total Liabilities soared 203.86% in 2024, then sank 39.51% in 2025.
- Silexion Therapeutics' Total Liabilities stood at $2.3 million in 2023, then jumped by 203.86% to $6.9 million in 2024, then slumped by 32.69% to $4.6 million in 2025, then decreased by 6.53% to $4.3 million in 2026.
- Business Quant data shows SLXN's Total Liabilities at $4.3 million in Q1 2026, $4.6 million in Q4 2025, and $4.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.64 Bn | 130.78 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 85.89 Bn | 77.90 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 65.11 Bn | 59.93 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 55.83 Bn | 50.69 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 42.01 Bn | 36.91 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.63 Bn | 28.32 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 27.65 Bn | 9.26 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.30 Bn | 26.47 Bn | - | 10.03 Bn |
| 10 | Silexion Therapeutics | 267,449.04 | -1.96 Mn | - | 4.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.20 Mn |
| Mar 31, 2026 | 4.31 Mn |
| Dec 31, 2025 | 4.61 Mn |
| Sep 30, 2025 | 4.64 Mn |
| Jun 30, 2025 | 5.68 Mn |
| Mar 31, 2025 | 5.72 Mn |
| Dec 31, 2024 | 6.85 Mn |
| Sep 30, 2024 | 7.67 Mn |
| Jun 30, 2024 | 2.37 Mn |
| Mar 31, 2024 | 3.59 Mn |
| Dec 31, 2023 | 2.26 Mn |